Search - tctmd.com

Displaying 21 - 40 of 93

Sort: Relevancy | Date

Presentation TCT 2019

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Presenter: Hoffmann Udo

September 28, 2019

Presentation TCT 2019

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Presenter: Francesco Franchi

September 27, 2019

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation CIT 2019

Dual Pathway Antithrombotic Inhibition for Stable Atherosclerosis

Presenter: Davide Capodanno

March 28, 2019

Presentation OPCI 2019

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Presenter: William F. Fearon

March 09, 2019

Presentation

FFR and Quality-of-Life Improvement After PCI in Patients With Stable CAD

October 03, 2018

Presentation TCT 2018

Benefits of Pretreatment With Dual Antiplatelet Therapy Prior to PCI in Stable CAD and ACS: Myth or Reality?

Presenter: John A. Bittl, C. Michael Gibson, Giuseppe Tarantini

September 23, 2018

Presentation TCT 2018

DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction

Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini

September 22, 2018

Presentation TCT 2018

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

Presenter: Jeroen J. Bax, Stephan Windecker, Adrian P. Banning

September 21, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Presenter: Rasha Al-Lamee

May 05, 2018

Presentation CHIP Florida 2018

Stable CAD: Work Up, Medical Therapy, PCI

Presenter: Jeffrey W. Moses

January 19, 2018

Presentation TCT 2017

Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora

November 01, 2017

Presentation iASSESS 2017

Stable Angina: PCI vs CABG vs OMT

Presenter: Robert T. Pyo

August 30, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation

Functional Testing or Coronary CT Angiographyin Patients With Stable CAD

April 03, 2017

Presentation TCT 2016

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate

November 01, 2016

Advertisement

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Dual Pathway Antithrombotic Inhibition for Stable Atherosclerosis

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

FFR and Quality-of-Life Improvement After PCI in Patients With Stable CAD

Benefits of Pretreatment With Dual Antiplatelet Therapy Prior to PCI in Stable CAD and ACS: Myth or Reality?

DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Stable CAD: Work Up, Medical Therapy, PCI

Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Stable Angina: PCI vs CABG vs OMT

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Functional Testing or Coronary CT Angiographyin Patients With Stable CAD

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content